The current study demonstrated the genotype-phenotype causal relationship between COQ2 mutations and dysfunctions of the mitochondrial respiratory chain and antioxidant action in neurons differentiated from iPSCs derived from MSA patients, suggesting the therapeutic potential of coenzyme Q10 for MSA patients with COQ2 mutation. Here, COQ2 is linked to multiple system atrophy.